133 related articles for article (PubMed ID: 16824707)
1. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
Hamdani J; Moës AJ; Amighi K
Int J Pharm; 2006 Sep; 322(1-2):96-103. PubMed ID: 16824707
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Hamdani J; Goole J; Moës AJ; Amighi K
Int J Pharm; 2006 Oct; 323(1-2):86-92. PubMed ID: 16815656
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of prolonged release pellets obtained by the melt pelletization process.
Hamdani J; Moës AJ; Amighi K
Int J Pharm; 2002 Oct; 245(1-2):167-77. PubMed ID: 12270253
[TBL] [Abstract][Full Text] [Related]
4. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
Sungthongjeen S; Paeratakul O; Limmatvapirat S; Puttipipatkhachorn S
Int J Pharm; 2006 Nov; 324(2):136-43. PubMed ID: 16828997
[TBL] [Abstract][Full Text] [Related]
6. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
7. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
Cheboyina S; Wyandt CM
Int J Pharm; 2008 Jul; 359(1-2):158-66. PubMed ID: 18499369
[TBL] [Abstract][Full Text] [Related]
8. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
9. Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets.
Hamdani J; Moës AJ; Amighi K
Int J Pharm; 2003 Jul; 260(1):47-57. PubMed ID: 12818809
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
12. [Controlled release of pseudoephedrine HCl from pellets].
Vertommen J
Verh K Acad Geneeskd Belg; 1997; 59(6):451-88. PubMed ID: 9543819
[TBL] [Abstract][Full Text] [Related]
13. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
Pauli-Bruns A; Knop K; Lippold BC
Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
Goole J; Vanderbist F; Amighi K
Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
[TBL] [Abstract][Full Text] [Related]
15. Optimization of melt pelletization in a high shear mixer.
Bukovec P; Kroselj V; Turk S; Vrecer F
Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
[TBL] [Abstract][Full Text] [Related]
16. Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique.
Zhai H; Jones DS; McCoy CP; Madi AM; Tian Y; Andrews GP
Mol Pharm; 2014 Oct; 11(10):3471-83. PubMed ID: 25105340
[TBL] [Abstract][Full Text] [Related]
17. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
[TBL] [Abstract][Full Text] [Related]
19. Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities.
Chen YC; Ho HO; Lee TY; Sheu MT
Int J Pharm; 2013 Jan; 441(1-2):162-9. PubMed ID: 23237874
[TBL] [Abstract][Full Text] [Related]
20. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
Fukuda M; Peppas NA; McGinity JW
J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
